Recognition of Impairment Losses on Investment Securities
First written in FY2022-Q1. 1 of 11 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2023: 1 of 7 companies on the "Worse" side.
5 other companies' latest entry also says "Other".
- FY2026Full-year actual results and presentation category updated for impairment loss on investment securitiesAnnual report
「During the current consolidated fiscal year, the Company recognized an impairment loss of ¥1 million on unlisted shares classified as other securities.」
The impairment loss on investment securities was ¥1 million in the current fiscal year. In the income statement, it is included under “Other” to improve clarity of presentation. - FY2026-H1Interim actual results updated for impairment loss on investment securitiesAnnual report
「Impairment loss on investment securities 2 1」
The impairment loss on investment securities for the current interim consolidated accounting period was ¥1 million, down from ¥2 million in the same period of the previous year. - FY2025-H1Interim actual results updated for impairment loss on investment securitiesAnnual report
「Impairment loss on investment securities 4 2」
The impairment loss on investment securities for the current interim consolidated accounting period was ¥2 million, down from ¥4 million in the same period of the previous year. - FY2024-Q2RestatedAnnual report
「Impairment loss on investment securities 0 4」
The impairment loss on investment securities for the second quarter of the current consolidated cumulative period was ¥4 million, unchanged from the cumulative first quarter. - FY2024-Q1First-quarter actual results updated for impairment loss on investment securitiesAnnual report
「Impairment loss on investment securities - 4」
During the first quarter of the current consolidated cumulative period, the Company recorded an impairment loss on investment securities of ¥4 million as an extraordinary loss. - FY2023Full-year actual results updated for impairment loss on investment securitiesAnnual report
「Impairment loss on investment securities 545 48」
The impairment loss on investment securities decreased from ¥545 million in the previous fiscal year to ¥48 million in the current fiscal year. - FY2023-Q3Third-quarter actual results updated for impairment loss on investment securitiesAnnual report
「Impairment loss on investment securities 545 0」
The impairment loss on investment securities for the third quarter of the current consolidated cumulative period was ¥0 million, down from ¥545 million in the same period of the previous year. - FY2023-Q1First-quarter actual results updated for impairment loss on investment securitiesAnnual report
「Loss on valuation of investment securities —」
No impairment loss on investment securities was recorded during the first quarter of the current consolidated cumulative period. This changed from ¥534 million in the first quarter of the previous consolidated fiscal year. - FY2022-Q3Third-quarter actual results updated for impairment loss on investment securitiesAnnual report
「Impairment loss on investment securities 12 545」
During the third quarter of the current consolidated cumulative period, the Company recorded an impairment loss on investment securities of ¥545 million. This was updated from ¥544 million for the cumulative second quarter. - FY2022-Q2Second-quarter actual results updated for impairment loss on investment securitiesAnnual report
「Impairment loss on investment securities 9 544」
During the second quarter of the current consolidated cumulative period, the Company recorded an impairment loss on investment securities of ¥544 million as an extraordinary loss. This was updated from ¥534 million in the first quarter. - FY2022-Q1First statedAnnual report
「Impairment loss on investment securities 534」
During the first quarter of the current consolidated cumulative period, the Company recorded an impairment loss on investment securities of ¥534 million as an extraordinary loss.